PD-1 monoclonal antibody drugs are injectable and require injection for treatment.
Currently commonly used pembrolizumab, nabulizumab are injection dosage form, are given by intravenous injection.PD-1 monoclonal antibody needs to be injected with a micropump or dissolved in dextrose solution or saline, and there are requirements for the injection time.PD-1 monoclonal antibody must be used under the guidance of a doctor, and should not be self-medicated.
PD-1 inhibitors are a kind of immunotherapy drugs for tumors, which can achieve the purpose of anti-tumor by strengthening the killing effect of the body’s own T lymphocytes. At present, the main PD-1 drugs include imported pabrolizumab and nabulizumab, as well as domestic sindilizumab, teraplizumab and karelizumab.